Terms: = Sarcomas AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Diagnosis
8 results:
1. hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Chaperones in Osteosarcoma: diagnosis and Therapeutic Issues.
Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation hsp90 inhibitor in Saos-2 osteosarcoma cells.
Özgür A
J Chemother; 2021 Dec; 33(8):554-563. PubMed ID: 33794753
[TBL] [Abstract] [Full Text] [Related]
4. Advances in sarcoma diagnostics and treatment.
Dancsok AR; Asleh-Aburaya K; Nielsen TO
Oncotarget; 2017 Jan; 8(4):7068-7093. PubMed ID: 27732970
[TBL] [Abstract] [Full Text] [Related]
5. Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma.
Cates JM; Memoli VA; Gonzalez RS
Virchows Arch; 2015 Aug; 467(2):211-6. PubMed ID: 25940995
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical analysis of expressions of RB1, CDK4, hsp90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma.
Wang T; Goodman MA; McGough RL; Weiss KR; Rao UN
Int J Surg Pathol; 2014 Oct; 22(7):589-99. PubMed ID: 24788530
[TBL] [Abstract] [Full Text] [Related]
7. hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
Terry J; Lubieniecka JM; Kwan W; Liu S; Nielsen TO
Clin Cancer Res; 2005 Aug; 11(15):5631-8. PubMed ID: 16061882
[TBL] [Abstract] [Full Text] [Related]
8. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
[TBL] [Abstract] [Full Text] [Related]
